Sabby Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Sabby Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-15,339	Closed	-$1.18M	–	215
2017 Q2	$1.01M	Buy	+15,339	New	+$1.9M	0.07%	99
2017 Q1	–	Sell	-6,254	Closed	-$893K	–	328
2016 Q4	$579K	Buy	6,254 +2,414	+63%	+$272K	0.03%	186
2016 Q3	$519K	Buy	3,840 +700	+22%	+$69.5K	0.02%	220
2016 Q2	$318K	Sell	3,140 -11,022	-78%	-$1.37M	0.02%	228
2016 Q1	$2.32M	Sell	14,162 -4,868	-26%	-$987K	0.12%	89
2015 Q4	$6.23M	Buy	19,030 +15,290	+409%	+$4.98M	0.34%	51
2015 Q3	$1.21M	Buy	+3,740	New	+$1.64M	0.05%	214
2014 Q3	–	Sell	-5,122	Closed	-$1.22M	–	304
2014 Q2	$1.22M	Buy	+5,122	New	+$1.04M	0.05%	132

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sabby Management's LUMO Position: Q3 2017 in Review

Sabby Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2017, closing a stake of 15,339 shares — an estimated $1.18M sold.

Sabby Management first reported a position in LUMO in Q2 2014 and held it in 8 quarters. The position peaked at $6.23M in Q4 2015. 126 funds tracked by Wall St. Rank hold LUMO as of Q3 2017.

Sabby Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Sabby Management sold 15,339 Lumos Pharma, Inc. Common Stock shares in Q3 2017, an estimated $1.18M.
Sabby Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2014 and held it in 8 quarters.
Sabby Management's Lumos Pharma, Inc. Common Stock position peaked at $6.23M in Q4 2015.
126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.